Revised SPC: Repatha SureClick (evolocumab)

Sections 4.2 and 4.4 have been updated to remove reference to the need for caution when used in patients with renal impairment. Section 5.1 has now been updated to include available data for use in patients with renal impairment.

Source:

electronic Medicines compendium